RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC)

Clinical trials for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC) explained in plain language.

Never miss a new study

Get alerted when new RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC) trials appear

Sign up with your email to follow new studies for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could changing when chemo is given boost cancer treatment success?

Disease control Recruiting now

This study is testing whether changing the timing and frequency of chemotherapy given alongside an immunotherapy drug (pembrolizumab) might work better for people with advanced head and neck cancer that has returned or spread. Researchers think the current standard schedule might…

Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC)

Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control

Last updated Mar 02, 2026 15:21 UTC

RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC)

Get alerted when new RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC) trials appear

Could changing when chemo is given boost cancer treatment success?